Immuron Limited (IMC.AX) News
Follow Immuron Limited (IMC.AX) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 2 public stories across 2 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Immuron Announces Annual General Meeting
Immuron will hold its annual general meeting on November 18, 2026, at Acclime Australia's offices in Carlton South, Victoria. Shareholders will vote on an additional 10% placement capacity, supplementing the existing 15%
REGULATION | Oct 16, 2026, 12:04 PM UTC
L
Immuron says Phase 2 Travelan trial results published in Scientific Reports
Immuron reported publication of Phase 2 results for once-daily oral Travelan in Scientific Reports; data were previously presented on March 7, 2024. The trial missed its primary efficacy targets, pressured by an unexpect
CENTRAL_BANK | Oct 13, 2026, 10:05 AM UTC